☆ 4.8 Editorial Material

Double or nothing on cancer immunotherapy

NATURE BIOTECHNOLOGY (2013)

期刊

NATURE BIOTECHNOLOGY

卷 31, 期 1, 页码 33-34

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/nbt.2471

关键词

-

类别

Biotechnology & Applied Microbiology

资金

NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER
Intramural NIH HHS [Z01 BC010763-03] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Oncology

Double-edged effects of interferons on the regulation of cancer-immunity cycle

Xiao Zhang, Song Wang, Yuanyuan Zhu, Minghui Zhang, Yan Zhao, Zhengbin Yan, Qiuxu Wang, Xiaobo Li

Summary: Interferons have a dual effect on cancer immune response, with both anti-cancer and immune escape-promoting effects. They regulate each step of the cancer immunity cycle, contributing to our understanding of the mechanisms of IFNs in regulating cancer immunity. Recent studies have highlighted the critical roles of IFNs in the success of cancer therapy strategies.

ONCOIMMUNOLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance

J. Kellogg Parsons, Peter A. Pinto, Christian P. Pavlovich, Edward Uchio, Mike N. Nguyen, Hyung L. Kim, James L. Gulley, Houssein Abdul Sater, Christina Jamieson, Chiu-Hsieh Hsu, Malgorzata Wojtowicz, Margaret House, Jeffrey Schlom, Renee N. Donahue, William L. Dahut, Ravi A. Madan, Shania Bailey, Sara Centuori, Julie E. Bauman, Howard L. Parnes, H. -H. Sherry Chow

Summary: This study investigated the immunologic response to the PROSTVAC vaccine and the clinical indicators of disease progression in patients with localized prostate cancer on active surveillance. The results showed that the PROSTVAC vaccine did not have better efficacy compared to the control group. Despite the negative findings, this is the first study to demonstrate the feasibility and acceptability of immunotherapy in the active surveillance setting for prostate cancer.

EUROPEAN UROLOGY FOCUS (2023)

添加到收藏夹

Review Medicine, General & Internal

Microbiome-Friend or Foe of Pancreatic Cancer?

Jaroslaw Daniluk, Urszula Daniluk, Pawel Rogalski, Andrzej Dabrowski, Agnieszka Swidnicka-Siergiejko

Summary: Pancreatic ductal adenocarcinoma is a deadly neoplasm with poor prognosis, and the human microbiome may play a role in its pathogenesis. This review summarizes the current understanding of how the microbiome influences pancreatic cancer development and progression, discusses its potential as a marker for diagnosis, progression, and survival, and explores the possibility of modifying the microbiome to improve treatment outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy

Xiang Xiong, Jingya Zhao, Rui Su, Chunping Liu, Xing Guo, Shaobing Zhou

Summary: The study introduces a novel strategy for enhanced tumor immunotherapy by combining different carriers to achieve targeted delivery to tumors and activation of immune response, resulting in improved efficacy in tumor therapy.

NANO TODAY (2021)

添加到收藏夹

Review Cell Biology

NF-kappa B in Cancer Immunity: Friend or Foe?

Guilhem Lalle, Julie Twardowski, Yenkel Grinberg-Bleyer

Summary: NF-kappa B plays a crucial role in immune responses to cancer and could be targeted by novel immunotherapies.

CELLS (2021)

添加到收藏夹

Article Astronomy & Astrophysics

Black holes and WIMPs: all or nothing or something else

Bernard Carr, Florian Kuehnel, Luca Visinelli

Summary: This study investigates constraints on primordial black holes in different mass ranges and the impact of weakly interacting massive particles on dark matter. It is found that WIMP annihilations have a specific effect on haloes formed around different mass primordial black holes. Furthermore, constraints on the PBH dark matter fraction are determined based on observations of the extragalactic gamma-ray background.

MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY (2021)

添加到收藏夹

Review Oncology

Double Guard Efficiency and Safety-Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients

Ewa Kalinka, Kamila Wojas-Krawczyk, Pawel Krawczyk

Summary: This manuscript discusses the use of immunotherapy in non-small cell lung cancer and the primary and secondary resistance mechanisms associated with it. The study highlights the importance of understanding and overcoming resistance to improve treatment outcomes. The concept of dual immunologic checkpoint blockade is explored as a potential strategy to avoid resistance and provide effective salvage treatment.

CANCERS (2023)

添加到收藏夹

Article Agricultural Economics & Policy

Double or Nothing: Impacts of Warming on Crop Quantity, Quality, and Revenue

A. Ford Ramsey, Jesse B. Tack, Maria Balota

Summary: This study quantifies the economic impact of projected warming on revenue of Virginia-type peanuts, using a unique data set from the Peanut Variety and Quality Evaluation program. The findings show that warmer temperatures have a symmetric and negative effect on yield and quality, leading to a sharp decline in farm revenues. Breeding gains in yield and quality can offset revenue losses under moderate warming of up to 1 degrees C, but are unlikely to sustain farm revenues under more extreme temperature changes.

JOURNAL OF AGRICULTURAL AND RESOURCE ECONOMICS (2022)

添加到收藏夹

Editorial Material Clinical Neurology

Making Up Missed Anti-Seizure Medication Doses: Double or Nothing?

Samuel W. Terman

Summary: This study aims to explore individualized remedial dosing regimens for delayed or missed doses of commonly used antiseizure medications. Monte Carlo simulation based on population pharmacokinetic models was employed to investigate six remedial strategies. It was found that the recommended remedial regimens were highly correlated to delayed time and the characteristics of the antiseizure medication. A web-based dashboard was developed to provide personalized remedial regimens.

EPILEPSY CURRENTS (2023)

添加到收藏夹

Article Computer Science, Theory & Methods

On security properties of all-or-nothing transforms

Navid Nasr Esfahani, Douglas R. Stinson

Summary: All-or-nothing transforms are defined as bijective mappings on all s-tuples over a specified finite alphabet, providing security under certain conditions. Perfect security is achieved if input s-tuples are equiprobable, while weaker security guarantees are still possible if they are not. Randomized AONTs can be used to provide perfect security for a smaller number of inputs, even when not equiprobable.

DESIGNS CODES AND CRYPTOGRAPHY (2021)

添加到收藏夹

Review Immunology

Cancer Vaccines: Promising Therapeutics or an Unattainable Dream

Howard Donninger, Chi Li, John W. Eaton, Kavitha Yaddanapudi

Summary: The emergence of cancer immunotherapy has brought new hope to cancer patients, although its effectiveness varies across different cancer types. Cancer vaccines offer an alternative method to balance the interaction between tumor cells and the host immune system.

VACCINES (2021)

添加到收藏夹

Article Management

Sales Effort Management Under All-or-Nothing Constraint

Longyuan Du, Ming Hu, Jiahua Wu

Summary: In the sales effort management problem with an all-or-nothing constraint, the optimal sales rate shows a nonmonotonic behavior with respect to remaining time or required sales volume. Various easy-to-compute heuristics are proposed, including a static heuristic and a modified resolving heuristic, to address the performance challenges and achieve asymptotic optimality with different performance losses.

MANAGEMENT SCIENCE (2022)

添加到收藏夹

Review Oncology

A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy

Chenyu Mao, Yongfeng Ding, Nong Xu

Summary: Cytokines play a crucial role in the treatment of prostate cancer, either aiding in tumor treatment or promoting tumor growth. The dosage and side effects of cytokines can impact treatment outcomes, as well as other immunotherapy methods used in prostate cancer treatment.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Chemistry, Multidisciplinary

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell

Lu Diao, Mi Liu

Summary: Cancer vaccines, particularly those loaded with whole-tumor antigens, show promising potential in overcoming limitations of pre-determined antigen-based vaccines. These vaccines include pan-spectra antigens, induce pan-clones specific T cells, and overcome heterogeneity of cancer cells. Recent advances in utilizing whole cancer cell lysates as antigens in cancer vaccines are summarized, highlighting the feasibility and benefits of this approach.

ADVANCED SCIENCE (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer

Jin Li, Chong Wan, Xiaoqi Li, Chenlian Quan, Xiaoqiu Li, Xiaohua Wu

Summary: This study reveals the significant role of double-stranded RNA-binding proteins (dsRBPs) in the regulation of prognosis and tumor immunology in cervical cancer. A risk model has been established for risk stratification and immunotherapy evaluation.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

添加到收藏夹

Article Oncology

Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models

Ling Zhang, John S. Davies, Carylinda Serna, Zhiya Yu, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan, Christian S. Hinrichs

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy

Eva Perez-Guijarro, Howard H. Yang, Romina E. Araya, Rajaa El Meskini, Helen T. Michael, Suman Kumar Vodnala, Kerrie L. Marie, Cari Smith, Sung Chin, Khiem C. Lam, Andres Thorkelsson, Anthony J. Iacovelli, Alan Kulaga, Anyen Fon, Aleksandra M. Michalowski, Willy Hugo, Roger S. Lo, Nicholas P. Restifo, Shyam K. Sharan, Terry Van Dyke, Romina S. Goldszmid, Zoe Weaver Ohler, Maxwell P. Lee, Chi-Ping Day, Glenn Merlino

NATURE MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Identification of Small Molecule Enhancers of Immunotherapy for Melanoma

Christopher Dextras, Myagmarjav Dashnyam, Lesley A. Mathews Griner, Janani Sundaresan, Bryan Chim, Zhiya Yu, Suman Vodnala, Chyi-Chia Richard Lee, Xin Hu, Noel Southall, Juan J. Marugan, Ajit Jadhav, Nicholas P. Restifo, Nicolas Acquavella, Marc Ferrer, Anju Singh

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Oncology

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies

Devikala Gurusamy, Amanda N. Henning, Tori N. Yamamoto, Zhiya Yu, Nikolaos Zacharakis, Krishna, Rigel J. Kishton, Suman K. Vodnala, Arash Eidizadeh, Li Jia, Christine M. Kariya, Mary A. Black, Robert Eil, Douglas C. Palmer, Jenny H. Pan, Madhusudhanan Sukumar, Shashank J. Patel, Nicholas P. Restifo

CANCER CELL (2020)

添加到收藏夹

Article Immunology

Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas

Devin Dersh, James D. Phelan, Megan E. Gumina, Boya Wang, Jesse H. Arbuckle, Jaroslav Holly, Rigel J. Kishton, Tovah E. Markowitz, Mina O. Seedhom, Nathan Fridlyand, George W. Wright, Da Wei Huang, Michele Ceribelli, Craig J. Thomas, Justin B. Lack, Nicholas P. Restifo, Thomas M. Kristie, Louis M. Staudt, Jonathan W. Yewdell

Summary: Genome-wide screening in diffuse large B cell lymphomas identified genes that modulate MHC-I cell surface expression in multiple pathways. These genes represent potential targets for manipulating MHC-I immunosurveillance in cancers and other diseases. Pharmacological inhibition of negative regulators of antigen presentation enhanced MHC-I presentation in DLBCL.

IMMUNITY (2021)

添加到收藏夹

Article Cell & Tissue Engineering

Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation

Selami Demirci, Juan J. Haro-Mora, Alexis Leonard, Claire Drysdale, Daniela Malide, Keyvan Keyvanfar, Khaled Essawi, Raul Vizcardo, Naritaka Tamaoki, Nicholas P. Restifo, John F. Tisdale, Naoya Uchida

STEM CELL RESEARCH & THERAPY (2020)

添加到收藏夹

Correction Biochemistry & Molecular Biology

Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy (vol 26, pg 781, 2020)

Eva Perez-Guijarro, Howard H. Yang, Romina E. Araya, Rajaa El Meskini, Helen T. Michael, Suman Kumar Vodnala, Kerrie L. Marie, Cari Smith, Sung Chin, Khiem C. Lam, Andres Thorkelsson, Anthony J. Iacovelli, Alan Kulaga, Anyen Fon, Aleksandra M. Michalowski, Willy Hugo, Roger S. Lo, Nicholas P. Restifo, Shyam K. Sharan, Terry Van Dyke, Romina S. Goldszmid, Zoe Weaver Ohler, Maxwell P. Lee, Chi-Ping Day, Glenn Merlino

NATURE MEDICINE (2021)

添加到收藏夹

Article Cell & Tissue Engineering

Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion

Keli L. Hippen, Scott N. Furlan, Rahul Roychoudhuri, Ena Wang, Yigang Zhang, Mark J. Osborn, Sarah C. Merkel, Sophia Hani, Margaret L. MacMillan, Frank Cichocki, Jeffrey S. Miller, John E. Wagner, Nicholas P. Restifo, Leslie S. Kean, Bruce R. Blazar

Summary: Human tTregs expanded through repetitive restimulation maintain their Treg gene expression pattern without developing the exhaustion signature of effector T cells. This method of expansion produces Tregs with stable FoxP3 expression and enhanced suppressor function, supporting the possibility of off-the-shelf Treg therapeutics.

CYTOTHERAPY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

An engineered IL-2 partial agonist promotes CD8+ T cell stemness

Fei Mo, Zhiya Yu, Peng Li, Jangsuk Oh, Rosanne Spolski, Liang Zhao, Caleb R. Glassman, Tori N. Yamamoto, Yun Chen, Filip M. Golebiowski, Dalton Hermans, Sonia Majri-Morrison, Lora K. Picton, Wei Liao, Min Ren, Xiaoxuan Zhuang, Suman Mitra, Jian-Xin Lin, Luca Gattinoni, Jonathan D. Powell, Nicholas P. Restifo, K. Christopher Garcia, Warren J. Leonard

Summary: Adoptive transfer of antigen-specific T cells is a significant advancement in cancer immunotherapy, and maintaining a stem-cell-like state before transfer is beneficial for therapeutic efficacy.

NATURE (2021)

添加到收藏夹

Review Immunology

Next generation immunotherapy: enhancing stemness of polyclonal T cells to improve anti-tumor activity

Rigel J. Kishton, Suman K. Vodnala, Raul Vizcardo, Nicholas P. Restifo

Summary: The administration of T cells as cellular therapy has shown clinical benefit in cancer patients. However, these therapies are not curative for most patients, especially those with solid tumors. Recent research has focused on understanding key factors that regulate the efficacy of T cell therapy and developing strategies to improve clinical outcomes in solid tumors.

CURRENT OPINION IN IMMUNOLOGY (2022)

添加到收藏夹

Article Oncology

A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers

Ken-ichi Hanada, Chihao Zhao, Raul Gil-Hoyos, Jared J. Gartner, Christopher Chow-Parmer, Frank J. Lowery, Sri Krishna, Todd D. Prickett, Scott Kivitz, Maria R. Parkhurst, Nathan Wong, Zachary Rae, Michael C. Kelly, Stephanie L. Goff, Paul F. Robbins, Steven A. Rosenberg, James C. Yang

Summary: This study proposes a signature to identify neoantigen-reactive T cells and demonstrates a successful rate of identifying such T cells using the signature. It provides a potential method for quick identification and engineering of personalized neoantigen-reactive T cells for therapy.

CANCER CELL (2022)

添加到收藏夹

Article Oncology

Identification of neoepitope reactive T-cell receptors guided by HLA-A03:01 and HLA-A11:01 immunopeptidomics

Catherine M. Ade, Matthew J. Sporn, Sudipto Das, Zhiya Yu, Ken-ichi Hanada, Yue A. Qi, Tapan Maity, Xu Zhang, Udayan Guha, Thorkell Andresson, James C. Yang

Summary: This article introduces a method of using mass spectrometry to identify common tumor-specific neoepitopes derived from mutated oncogenes, and develop TCRs based on these data. The results of the study show that this method successfully identified precise neoepitopes derived from KRAS, EGFR, BRAF, and PIK3CA presented by HLA-A*03:01 and/or HLA-A*11:01 across multiple biological replicates.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

添加到收藏夹

Article Oncology

A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types

Jared J. Gartner, Maria R. Parkhurst, Alena Gros, Eric Tran, Mohammad S. Jafferji, Amy Copeland, Ken-Ichi Hanada, Nikolaos Zacharakis, Almin Lalani, Sri Krishna, Abraham Sachs, Todd D. Prickett, Yong F. Li, Maria Florentin, Scott Kivitz, Samuel C. Chatmon, Steven A. Rosenberg, Paul F. Robbins

Summary: Robbins and colleagues developed and tested a machine learning model for ranking tumor neoantigens, aiding in the identification of potential therapeutic targets for future immunotherapies. The model showed improved sensitivity and specificity by incorporating multiple factors impacting epitope presentation and recognition, compared to using predicted HLA binding alone. The ranked output provides a list of potential neoantigens for further in vitro and in vivo studies, facilitating the development of more effective immunotherapies.

NATURE CANCER (2021)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

Strength in Numbers: Identifying Neoantigen Targets for Cancer Immunotherapy

Rigel J. Kishton, Rachel C. Lynn, Nicholas P. Restifo

CELL (2020)

添加到收藏夹

Article Medicine, Research & Experimental

An effective mouse model for adoptive cancer immunotherapy targeting neoantigens

Ken-ichi Hanada, Zhiya Yu, Gabrielle R. Chappell, Adam S. Park, Nicholas P. Restifo

JCI INSIGHT (2019)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.